Immediate Anterior Chamber Paracentesis With A 30-Gauge Needle for Acute Primary Angle - Closure

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study was to evaluate the efficacy and safety of immediate anterior chamber paracentesis (ACP) with a 30-gauge needle as an initial treatment for acute primary angle closure (APAC).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Siriraj Hospital
• Treatments: Acetazolamide

Criteria

Inclusion Criteria:

• patients aged more than 18 year old with the first attack of APAC

• IOP of more than or equal to 40 mmHg.

Exclusion Criteria:

• patient unable to cooperate for paracentesis

• patients with APAC in the only remaining eye

• patients received any glaucoma treatments prior to the study

• patients with secondary causes of acute angle closure

• patients with intraocular inflammation or infection; (6) patients with APAC in the eye with a history of previous intraocular surgery

• patients known hypersensitive to tetracaine hydrochloride or tobramycin.